Trials / Withdrawn
WithdrawnNCT03563352
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
Evaluating Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements for Oncologic Patients - A Cross-Sectional Survey Study at Norris Comprehensive Cancer Center
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of Southern California · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial studies nutritional preferences and product accessibility in oral nutritional supplements in participants with breast, colorectal, upper gastrointestinal, or prostate cancer. Learning what participants like and dislike about their current or past used nutritional supplements may help doctor know how to improve them.
Detailed description
PRIMARY OBJECTIVES: I. Identify how patients with cancer are obtaining nutrition to support medical management. SECONDARY OBJECTIVES: I. Examine associations of gastrointestinal side effects with specific diagnoses and respective medical therapies. II. Understand how patients access information regarding nutritional supplements. III. Evaluate patient satisfaction with currently available oral nutritional supplements (ONS). IV. Identify patient preferences in formulating a novel nutritional supplement. OUTLINE: Participants attend an interview over 15 minutes and complete surveys.
Conditions
- Breast Carcinoma
- Cholangiocarcinoma
- Colorectal Carcinoma
- Gastric Carcinoma
- Malignant Digestive System Neoplasm
- Pancreatic Carcinoma
- Prostate Carcinoma
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Interview | Attend an interview |
| OTHER | Survey Administration | Ancillary studies |
Timeline
- Start date
- 2018-08-30
- Primary completion
- 2020-09-24
- Completion
- 2020-09-24
- First posted
- 2018-06-20
- Last updated
- 2020-12-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03563352. Inclusion in this directory is not an endorsement.